Drug intelligence / Profile preview

Asepxia

Development stage: Unknown
Lead developer: Genomma Lab
Modality: Small Molecules

Overview

Asepxia is a brand of over-the-counter (OTC) topical acne treatments developed and marketed by Genomma Lab. The product line includes various formulations such as cleansers, bar soaps, creams, and lotions designed to treat acne vulgaris. These products primarily utilize active ingredients like salicylic acid (typically 1-2%) and benzoyl peroxide (up to 10%). Salicylic acid acts as a keratolytic agent, helping to exfoliate the skin and clear pores by breaking down keratin, while benzoyl peroxide provides antimicrobial activity against *Cutibacterium acnes* through the release of free radical oxygen. The brand is positioned as a comprehensive skincare solution for managing pimples, blackheads, and skin blemishes in the consumer health market.

Brand names: Asepxia

Beyond the preview

Go deeper on Asepxia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asepxia.

Explore the full profile